ロード中...
Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
BACKGROUND: Neovascular age-related macular degeneration (nAMD) has been treated with anti-vascular endothelial growth factor (anti-VEGF) therapy since 2006 with initial efficacy evidence of 2 years. In many, long-term therapy is required, and evidence for benefit is required from real-world data co...
保存先:
| 出版年: | Clin Ophthalmol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837532/ https://ncbi.nlm.nih.gov/pubmed/33519189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S269162 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|